<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0305">
 <label>61</label>
 <element-citation publication-type="book" id="sbref0305">
  <person-group person-group-type="author">
   <name>
    <surname>Borba</surname>
    <given-names>M.G.S.</given-names>
   </name>
   <name>
    <surname>Val F de</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sampaio</surname>
    <given-names>V.S.</given-names>
   </name>
   <name>
    <surname>Alexandre</surname>
    <given-names>M.A.A.</given-names>
   </name>
   <name>
    <surname>Melo</surname>
    <given-names>G.C.</given-names>
   </name>
   <name>
    <surname>Brito</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <chapter-title>Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)</chapter-title>
  <year>2020</year>
  <publisher-name>medRxiv</publisher-name>
  <pub-id pub-id-type="doi">10.1101/2020.04.07.20056424</pub-id>
  <comment>2020.04.07.20056424</comment>
 </element-citation>
</ref>
